Tags

Type your tag names separated by a space and hit enter

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Eur J Immunol 2012; 42(7):1755-66EJ

Abstract

Antigen-specific antibodies are well characterized after vaccination with pandemic H1N1 or seasonal influenza vaccines. However, knowledge on cellular immunity toward pandemic H1N1 after vaccination and infection and cross-reactivities toward seasonal antigens is limited. Nineteen individuals were vaccinated with the pandemic H1N1 vaccine. Among those, ten had been prevaccinated against seasonal influenza. CD4(+) T cells specific for pandemic H1N1 and for seasonal vaccine, and antibodies were monitored using flow cytometry and ELISA/neutralization assays, respectively. In addition, seven patients with acute pandemic influenza infection were analyzed. Pandemic H1N1 vaccination induced a strong 4.63-fold (IQR 4.16) increase in antigen-specific CD4(+) T cells that was more pronounced in individuals not prevaccinated with seasonal influenza (p = 0.01). T-cell levels toward seasonal vaccine concomitantly rose by 2.71-fold (IQR 2.26). Likewise, prevaccination with seasonal influenza induced a less pronounced increase in specific antibodies. Influenza-specific T cells in vaccinees had a Th1 phenotype mainly coexpressing IFN-γ and IL-2, whereas patients with active pandemic influenza showed a shift toward cells predominantly expressing IFN-γ. In conclusion, T cells toward seasonal influenza antigens cross-react with pandemic H1N1 antigens and affect induction of specific T cells after pandemic influenza vaccination. In addition, the cytokine patterns of specific T cells during acute H1N1 infection and after vaccination differ, and the predominantly dual-positive cytokine profile of vaccine-induced T cells suggests sufficient functionality to confer successful virus control.

Authors+Show Affiliations

Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22585549

Citation

Schmidt, Tina, et al. "CD4+ T-cell Immunity After Pandemic Influenza Vaccination Cross-reacts With Seasonal Antigens and Functionally Differs From Active Influenza Infection." European Journal of Immunology, vol. 42, no. 7, 2012, pp. 1755-66.
Schmidt T, Dirks J, Enders M, et al. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. Eur J Immunol. 2012;42(7):1755-66.
Schmidt, T., Dirks, J., Enders, M., Gärtner, B. C., Uhlmann-Schiffler, H., Sester, U., & Sester, M. (2012). CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. European Journal of Immunology, 42(7), pp. 1755-66. doi:10.1002/eji.201242393.
Schmidt T, et al. CD4+ T-cell Immunity After Pandemic Influenza Vaccination Cross-reacts With Seasonal Antigens and Functionally Differs From Active Influenza Infection. Eur J Immunol. 2012;42(7):1755-66. PubMed PMID: 22585549.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. AU - Schmidt,Tina, AU - Dirks,Jan, AU - Enders,Martin, AU - Gärtner,Barbara C, AU - Uhlmann-Schiffler,Heike, AU - Sester,Urban, AU - Sester,Martina, PY - 2012/5/16/entrez PY - 2012/5/16/pubmed PY - 2012/12/10/medline SP - 1755 EP - 66 JF - European journal of immunology JO - Eur. J. Immunol. VL - 42 IS - 7 N2 - Antigen-specific antibodies are well characterized after vaccination with pandemic H1N1 or seasonal influenza vaccines. However, knowledge on cellular immunity toward pandemic H1N1 after vaccination and infection and cross-reactivities toward seasonal antigens is limited. Nineteen individuals were vaccinated with the pandemic H1N1 vaccine. Among those, ten had been prevaccinated against seasonal influenza. CD4(+) T cells specific for pandemic H1N1 and for seasonal vaccine, and antibodies were monitored using flow cytometry and ELISA/neutralization assays, respectively. In addition, seven patients with acute pandemic influenza infection were analyzed. Pandemic H1N1 vaccination induced a strong 4.63-fold (IQR 4.16) increase in antigen-specific CD4(+) T cells that was more pronounced in individuals not prevaccinated with seasonal influenza (p = 0.01). T-cell levels toward seasonal vaccine concomitantly rose by 2.71-fold (IQR 2.26). Likewise, prevaccination with seasonal influenza induced a less pronounced increase in specific antibodies. Influenza-specific T cells in vaccinees had a Th1 phenotype mainly coexpressing IFN-γ and IL-2, whereas patients with active pandemic influenza showed a shift toward cells predominantly expressing IFN-γ. In conclusion, T cells toward seasonal influenza antigens cross-react with pandemic H1N1 antigens and affect induction of specific T cells after pandemic influenza vaccination. In addition, the cytokine patterns of specific T cells during acute H1N1 infection and after vaccination differ, and the predominantly dual-positive cytokine profile of vaccine-induced T cells suggests sufficient functionality to confer successful virus control. SN - 1521-4141 UR - https://www.unboundmedicine.com/medline/citation/22585549/CD4+_T_cell_immunity_after_pandemic_influenza_vaccination_cross_reacts_with_seasonal_antigens_and_functionally_differs_from_active_influenza_infection_ L2 - https://doi.org/10.1002/eji.201242393 DB - PRIME DP - Unbound Medicine ER -